Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

Patentability of antibodies for therapeutic use in Europe

General guidelines are presented on the types of patent protection available for inventions arising from research in the field of monoclonal antibodies, using concepts drawn from European case law and expert practice.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. European Patent Office. European Patent Convention, 15th edn (European Patent Office, 2013).

  2. Ballester Rodé s, A. et al. (eds) Case Law of the Boards of Appeal of the European Patent Office 8th edn, 275–278 (European Patent Office, 2016).

    Google Scholar 

  3. Eli Lilly & Co. v. Human Genome Sciences Inc., C-493/12 (2013).

  4. European Patent Office. Guidelines for Examination in the European Patent Office 747–749 (European Patent Office, 2017).

  5. Art. 53(c) EPC.

  6. Arts. 54(4) and 54(5) EPC.

  7. EPO Board of Appeal decisions: T499/88 (EP59598: Immunoglobulins/Unilever), T36/90 (EP 676642: Tumor cells/Bogoch), T906/91 (EP 198179: Monoclonal antibody to theophylline/DuPont).

  8. EP 0865448 (12 June 1997).

  9. EPO Board of Appeal rulings: T355/92 (EP 193880: anti-FSH antibody (Boehringer Mannheim), T510/94 (EP 125722: Monoclonal antibody OKT5/ORTHO).

  10. Ballester Rodés, A. et al. (eds) Case Law of the Boards of Appeal of the European Patent Office 8th edn. 201–203 (European Patent Office, 2016).

    Google Scholar 

  11. EPO Board of Appeal decision T1212/97 (EP1125023: Immunoglobulin preparation/Genentech).

  12. Art. 83 EPC.

  13. European Patent Office. Guidelines for Examination in the European Patent Office 689–691 (European Patent Office, 2012).

  14. Art. 56 EPC.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patrizia Rampinelli.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Germinario, C., Bertoli, S., Rampinelli, P. et al. Patentability of antibodies for therapeutic use in Europe. Nat Biotechnol 36, 402–405 (2018). https://doi.org/10.1038/nbt.4134

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.4134

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research